🩸🔬 Targeted therapies for blood cancer are evolving fast!
From ligand-functionalized nanoparticles to AI-driven delivery—precision is the new standard. Review from #RSCPharma AB member Yahya Choonara and co-workers, @WitsUniversity
🔗 buff.ly/WVaBmwZ
#BloodCancer #Nanomedicine #DrugDelivery
From ligand-functionalized nanoparticles to AI-driven delivery—precision is the new standard. Review from #RSCPharma AB member Yahya Choonara and co-workers, @WitsUniversity
🔗 buff.ly/WVaBmwZ
#BloodCancer #Nanomedicine #DrugDelivery
Advances in targeted therapies and emerging strategies for blood cancer treatment
Blood cancers, including leukemia, lymphoma, and multiple myeloma, originate within the bone marrow, where the intricate microenvironment presents considerable challenges for conventional therapies…
buff.ly
September 20, 2025 at 3:14 PM
🩸🔬 Targeted therapies for blood cancer are evolving fast!
From ligand-functionalized nanoparticles to AI-driven delivery—precision is the new standard. Review from #RSCPharma AB member Yahya Choonara and co-workers, @WitsUniversity
🔗 buff.ly/WVaBmwZ
#BloodCancer #Nanomedicine #DrugDelivery
From ligand-functionalized nanoparticles to AI-driven delivery—precision is the new standard. Review from #RSCPharma AB member Yahya Choonara and co-workers, @WitsUniversity
🔗 buff.ly/WVaBmwZ
#BloodCancer #Nanomedicine #DrugDelivery
RSC Pharmaceutics was recently indexed in DOAJ!! 🎉
Discover RSC Pharmaceutics articles here 📢 rsc.li/RSCPharma
Discover RSC Pharmaceutics articles here 📢 rsc.li/RSCPharma
March 20, 2025 at 10:14 AM
RSC Pharmaceutics was recently indexed in DOAJ!! 🎉
Discover RSC Pharmaceutics articles here 📢 rsc.li/RSCPharma
Discover RSC Pharmaceutics articles here 📢 rsc.li/RSCPharma